Cervical Adenosquamous Cell Carcinoma Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039442Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerTreatment